Mellanox (MLNX) Merger Class Action Lawsuit: Halper Sadeh LLP Announces Filing of Shareholder Class Action Lawsuit Against Mellanox Technologies, Ltd. Concerning Its Proposed Merger With NVIDIA Corporation – MLNX
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces the filing of a shareholder class action lawsuit against Mellanox Technologies, Ltd. (“Mellanox” or the “Company”) (NASDAQ: MLNX) in connection with the proposed sale of Mellanox to NVIDIA Corporation (“NVIDIA”).
If you are a Mellanox shareholder and would like to discuss your legal rights and options, please visit Mellanox (MLNX) Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
The lawsuit alleges that Defendants issued a materially misleading proxy statement recommending that Mellanox shareholders vote in favor of the proposed transaction. According to the complaint, the proxy statement contains materially incomplete and/or misleading information concerning Mellanox’s financial projections and the analyses performed by the Company’s financial advisor in connection with the proposed transaction. As a result, Mellanox shareholders must be provided with this information in order to adequately assess and value the merger consideration. The lawsuit seeks to enjoin the shareholder vote on the proposed transaction until such information is disclosed.
If you are a Mellanox shareholder and would like to discuss your legal rights and options, please visit https://halpersadeh.com/actions/mellanox-technologies-ltd-mlnx-merger-nvidia-stock/ or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.